Recombinant SARS-CoV-2 Spike anticorps (B.1.351 – beta)

N° du produit ABIN7515621

Détail du produit anti-SARS-CoV-2 Spike anticorps

Antigène: SARS-CoV-2 Spike

Type d'anticorp: Recombinant Antibody

Épitope: B.1.351 – beta

Reactivité: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Beta

Hôte: Human

Clonalité: Monoclonal

Conjugué: Cet anticorp SARS-CoV-2 Spike est non-conjugé

Application: ELISA, Neutralization (Neut)

Fonction: Recombinant human monoclonal antibody raised against SARS-CoV-2 Beta Variant S.

Specificité: Reacts with RBD domain of spike protein of SARS-CoV-2, including South Africa variant (B.1.351) and UK variant (B.1.1.7).

Réactivité croisée: SARS Coronavirus-2 (SARS-CoV-2)

Immunogène: Recombinant protein corresponding to SARS-CoV-2 Variant B.1.351 S.

Isotype: IgG

Information d'application

Indications d'application: ELISA,Neutralization Assay,The optimal working dilution should be determined by the end user.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: In PBS (40 % glycerol).

Stock: 4 °C,-20 °C

Stockage commentaire: Store at 4°C is stable for 6 months from the date of shipment. For long term storage, store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Détails sur SARS-CoV-2 Spike

Antigène: SARS-CoV-2 Spike

Abstract: SARS-CoV-2 Spike Produits

Synonymes: anticorps E2, anticorps E2 glycoprotein precursor, anticorps Surface Glycoprotein, anticorps S

Classe de substances: Viral Protein